Stress Reduction in Ovarian Cancer

University of Wisconsin (UW)

Status

Completed

Conditions

Ovarian, Fallopian, and Primary Peritoneal Cancer

Treatments

Other: Attention control

Behavioral: Daily stress reduction program

Study type

Interventional

Funder types

Other

Identifiers

NCT01790789

A532800 (Other Identifier)

NCI-2013-01401 (Registry Identifier)

OS12706 (Other Identifier)

2013-0027 (Other Identifier)

SMPH\OBSTET & GYNECOL\OB-GYN (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.

Enrollment

41 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects must have an initial diagnosis of ovarian, fallopian tube or primary peritoneal cancer who completed primary ovarian cancer surgery or 3 cycles of neoadjuvant chemotherapy with interval cytoreductive surgery (ICS).
Final pathology diagnosis of stage I-IV ovarian, fallopian tube or primary peritoneal cancer with plan to receive primary adjuvant chemotherapy or completion of chemotherapy after ICS.
Receive chemotherapy at the University of Wisconsin-Madison.
Subjects must be at least 18 years of age.
English-speaking
Subjects must be able to use audio media, and read and understand the study manual.
ECOG performance status 0-2.
Subjects must have a phone.

Exclusion criteria

Subjects participating in a meditation practice more than 1 hour per week prior to surgery and/or chemotherapy administration.
Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer.
Subjects with diagnosis of Chronic Fatigue Syndrome (CFS).
Subjects unable to use audio media due to auditory dysfunction.
Subjects unable to read written English.
Subjects who are prisoners or incarcerated.